Skip to content

Blood glucose test (glucose dehydrogenase) and biochemical analyzer were used to determine the accuracy of blood glucose.

Blood glucose test (glucose dehydrogenase) and biochemical analyzer were used to determine the accuracy of blood glucose.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014424
Enrollment
Unknown
Registered
2018-01-12
Start date
2017-09-01
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monitoring of blood glucose levels in diabetics

Interventions

Gold Standard:Beckman AU5800 biochemical analyzer
test&#32
(glucose&#32
dehydrogenase)&#32

Sponsors

Beijing traditional medicine hospital affiliated to capital medical university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) the normal population and people with typical symptoms of diabetes; 2) age: all ages except newborn infants; 3) gender: no limit; 4) the blood glucose test was performed in the outpatient and inpatient patients, and the venous blood was extracted for other tests, and the measured values were in the measurable range.Select some samples with hypertension and hyperlipidemia; 5) patients voluntarily participate in clinical trials and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) samples of anticoagulants with EDTA and heparin were used; 2) the range of hematocrit is over 20%~65%; 3) high levels of acetaminophen, uric acid, ascorbic acid (vitamin C) and other reductive substances in the samples; 4) the triglyceride in the blood sample was higher than 3000mg/dL, 33.9mmol/L or cholesterol was higher than 500mg/dL or 12.95mmol/L; 5) Samples of patients with hypotension and shock; 6) sample of patients with ketosis; 7) samples of patients in the dehydration state; 8) samples that exceed the range of test reagents, sample size, contaminated samples and samples with no clinical ID number should be excluded; 9) serious mental illness or other conditions cause the patient to be unable to sign informed consent and uncooperative patients.

Design outcomes

Primary

MeasureTime frame
SPE, SEN, ACC;

Countries

China

Contacts

Public ContactYi Jinghong

Beijing traditional medicine hospital affiliated to capital medical university

kycyjh@sina.com+86 13693194180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026